Alliancebernstein L.P. Annexon, Inc. Transaction History
Alliancebernstein L.P.
- $280 Billion
- Q4 2024
A detailed history of Alliancebernstein L.P. transactions in Annexon, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 111,300 shares of ANNX stock, worth $300,510. This represents 0.0% of its overall portfolio holdings.
Number of Shares
111,300
Previous 127,360
12.61%
Holding current value
$300,510
Previous $753,000
24.3%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ANNX
# of Institutions
155Shares Held
98MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$20 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$18.9 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$17.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$17 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$15.2 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $129M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...